Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Baumgartner

Showing results (121-130 of 131) with videos related to

Pageof 14
Sort By:
Organic Letters|December 12, 2018
A Highly Stable Organic Radical CationMathilde Berville, Jimmy Richard, Monika Stolar, et al.
Schizophrenia Bulletin|September 6, 2022
Multimodal Magnetic Resonance Imaging Depicts Widespread and Subregion Specific Anomalies in the Thalamus of Early-Psychosis and Chronic Schizophrenia PatientsYasser Alemán-Gómez, Thomas Baumgartner, Paul Klauser, et al.
European Radiology Experimental|May 6, 2026
Monitoring carotid arterial stiffness using non-contrast-enhanced 4D MR angiographyIsabel Montón Quesada, Thomas Baumgartner, Augustin C Ogier, et al.
Angewandte Chemie (International Ed. in English)|April 7, 2023
Not So Innocent After All: Interfacial Chemistry Determines Charge-Transport Efficiency in Single-Molecule JunctionsAbdalghani Daaoub, James M F Morris, Vanessa A Béland, et al.
BMC Infectious Diseases|August 26, 2018
Association of the Tyrosine/Nitrotyrosine pathway with death or ICU admission within 30 days for patients with community acquired pneumoniaThomas Baumgartner, Giedré Zurauskaité, Yannick Wirz, et al.
Journal of Clinical Medicine|August 26, 2022
Sex-Related Differences in Patient Selection for and Outcomes after Pace and Ablate for Refractory Atrial Fibrillation: Insights from a Large Multicenter CohortThomas Baumgartner, Miriam Kaelin-Friedrich, Karol Makowski, et al.
Revue Medicale Suisse|January 15, 2025
[Neurology: what's new in 2024]Thomas Baumgartner, Giovanni Di Liberto, Valentin Loser, et al.
Eclinicalmedicine|September 21, 2022
Canakinumab in patients with COVID-19 and type 2 diabetes - A multicentre, randomised, double-blind, placebo-controlled trialMatthias Hepprich, Jonathan M Mudry, Claudia Gregoriano, et al.
Revue Medicale Suisse|January 22, 2026
[Neurology : what's new in 2025]Andria Tziakouri, Valentin Loser, Alex Vicino, et al.
Nature Medicine|September 17, 2025
An implantable system to restore hemodynamic stability after spinal cord injuryAaron A Phillips, Aasta P Gandhi, Nicolas Hankov, et al.
Pageof 14

Showing results (121-130 of 131) with videos related to

Sort By:
Pageof 14
Organic Letters|December 12, 2018
A Highly Stable Organic Radical CationMathilde Berville, Jimmy Richard, Monika Stolar, et al.
Schizophrenia Bulletin|September 6, 2022
Multimodal Magnetic Resonance Imaging Depicts Widespread and Subregion Specific Anomalies in the Thalamus of Early-Psychosis and Chronic Schizophrenia PatientsYasser Alemán-Gómez, Thomas Baumgartner, Paul Klauser, et al.
European Radiology Experimental|May 6, 2026
Monitoring carotid arterial stiffness using non-contrast-enhanced 4D MR angiographyIsabel Montón Quesada, Thomas Baumgartner, Augustin C Ogier, et al.
Angewandte Chemie (International Ed. in English)|April 7, 2023
Not So Innocent After All: Interfacial Chemistry Determines Charge-Transport Efficiency in Single-Molecule JunctionsAbdalghani Daaoub, James M F Morris, Vanessa A Béland, et al.
BMC Infectious Diseases|August 26, 2018
Association of the Tyrosine/Nitrotyrosine pathway with death or ICU admission within 30 days for patients with community acquired pneumoniaThomas Baumgartner, Giedré Zurauskaité, Yannick Wirz, et al.
Journal of Clinical Medicine|August 26, 2022
Sex-Related Differences in Patient Selection for and Outcomes after Pace and Ablate for Refractory Atrial Fibrillation: Insights from a Large Multicenter CohortThomas Baumgartner, Miriam Kaelin-Friedrich, Karol Makowski, et al.
Revue Medicale Suisse|January 15, 2025
[Neurology: what's new in 2024]Thomas Baumgartner, Giovanni Di Liberto, Valentin Loser, et al.
Eclinicalmedicine|September 21, 2022
Canakinumab in patients with COVID-19 and type 2 diabetes - A multicentre, randomised, double-blind, placebo-controlled trialMatthias Hepprich, Jonathan M Mudry, Claudia Gregoriano, et al.
Revue Medicale Suisse|January 22, 2026
[Neurology : what's new in 2025]Andria Tziakouri, Valentin Loser, Alex Vicino, et al.
Nature Medicine|September 17, 2025
An implantable system to restore hemodynamic stability after spinal cord injuryAaron A Phillips, Aasta P Gandhi, Nicolas Hankov, et al.
Pageof 14